Nyxoah (NYXH) Return on Capital Employed (2022 - 2026)
Nyxoah (NYXH) recorded quarterly Return on Capital Employed of 34847.58% in Q1 2026, down 288.36% quarter-over-quarter from 18500.99% in Q2 2025, and down 5053108.0% on a YoY basis from N/an in Q1 2025.
Nyxoah (NYXH) Return on Capital Employed (2022 - 2026) Analysis & Trends
Nyxoah's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 34847.58% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 5053108.0% year-over-year to 34847.58%; the TTM figure through Mar 2026 stood at 34847.58% (down 5053108.0% YoY), while the FY2025 annual figure was 100.58%, down 5165.0% from the prior year.
- Return on Capital Employed was 34847.58% for Q1 2026 at Nyxoah, down from 18500.99% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 25233.51% in Q4 2024 to a low of 34847.58% in Q1 2026.
- Historically, Return on Capital Employed has averaged 13238.21% across 5 years, with a median of 17984.5% in 2025.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed surged 1750956 bps in 2023, then plunged 5053108 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 18567.55% in 2022, then grew by 11 bps to 20669.09% in 2023, then increased by 22 bps to 25233.51% in 2024, then retreated by 27 bps to 18500.99% in 2025, then slumped by 288 bps to 34847.58% in 2026.
- The last three Return on Capital Employed figures came in at 34847.58% (Q1 2026), 18500.99% (Q2 2025), and 15683.5% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | -34,847.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,847.58% |
| Jun 30, 2025 | 18,500.99% |
| Mar 31, 2025 | 15,683.50% |
| Dec 31, 2024 | 25,233.51% |
| Sep 30, 2024 | 19,383.24% |
| Jun 30, 2024 | 22,240.09% |
| Mar 31, 2024 | 24,317.80% |
| Dec 31, 2023 | 20,669.09% |
| Sep 30, 2023 | 17,468.01% |
| Jun 30, 2023 | 16,616.61% |
| Mar 31, 2023 | 16,828.40% |
| Dec 31, 2022 | 18,567.55% |
| Sep 30, 2022 | -41.56% |
| Mar 31, 2022 | 4,715.32% |